KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Change in Accured Expenses (2018 - 2025)

Historic Change in Accured Expenses for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $7.5 million.

  • Progyny's Change in Accured Expenses rose 7474.25% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 1395.86%. This contributed to the annual value of $9.9 million for FY2024, which is 421.77% down from last year.
  • As of Q3 2025, Progyny's Change in Accured Expenses stood at $7.5 million, which was up 7474.25% from -$11.7 million recorded in Q2 2025.
  • Progyny's 5-year Change in Accured Expenses high stood at $17.5 million for Q1 2025, and its period low was -$11.7 million during Q2 2025.
  • Its 5-year average for Change in Accured Expenses is $2.6 million, with a median of $2.1 million in 2023.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 55800.08% in 2021, then surged by 724032.26% in 2022.
  • Progyny's Change in Accured Expenses (Quarter) stood at -$10.9 million in 2021, then soared by 70.81% to -$3.2 million in 2022, then surged by 56.55% to -$1.4 million in 2023, then crashed by 131.96% to -$3.2 million in 2024, then soared by 332.7% to $7.5 million in 2025.
  • Its Change in Accured Expenses was $7.5 million in Q3 2025, compared to -$11.7 million in Q2 2025 and $17.5 million in Q1 2025.